STOCK MARKET BSE NSE

Seven volunteers found ineligible for coronavirus vaccine trial due to 'medical reasons'

'All seven candidates who were selected on Monday have become ineligible due to various medical reasons, including antibody test coming positive for some,' said Dr Murlidhar Tambe.

Published: 22nd September 2020 11:38 PM  |   Last Updated: 22nd September 2020 11:38 PM   |  A+A-

Coronavirus, Vaccine

The phase III trial process began on Monday at the government-run hospital. (Photo | Shekhar Yadav, EPS)

By PTI

PUNE: Seven volunteers selected for phase III human clinical trial of the Oxford vaccine for COVID-19 at Pune's Sassoon General Hospital were declared "ineligible" to proceed further for various reasons, including testing positive for antibodies, an official said on Tuesday.

The phase III trial process began on Monday at the government-run hospital.

"All seven candidates who were selected on Monday have become ineligible due to various medical reasons, including antibody test coming positive for some," said Dr Murlidhar Tambe, Dean, Sassoon General Hospital.

"Some more candidates have been screened today (Tuesday) and if their results in the antibody and COVID-19 tests are negative and if they are eligible on other medical grounds, they will be administered vaccine candidate," he added.

​CLICK HERE FOR COVID-19 LIVE UPDATES

Phase II trials of the vaccine were carried out in Bharti Vidyapeeth Medical College and KEM Hospital in the city.

The city-based Serum Institute of India has partnered with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, being developed by the University of Oxford, UK.

Earlier this month, SII had paused the clinical trials of the vaccine candidate in the country.

The Drugs Controller General of India (DCGI) had, on September 11, directed SII to suspend any new recruitment in the phase II and III clinical trials till further orders after AstraZeneca paused trials in other countries because of "an unexplained illness" in a participant in the study.

However, on September 15, the DCGI gave permission to SII to resume trials.

ALSO WATCH:



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

IPL_2020
flipboard facebook twitter whatsapp